Susan Choe, DO | |
Lahey Outpatient Center @ Danvers, 480 Maple Street 1st Fl, Danvers, MA 01923 | |
(978) 304-8360 | |
Not Available |
Full Name | Susan Choe |
---|---|
Gender | Female |
Speciality | Endocrinology |
Experience | 12 Years |
Location | Lahey Outpatient Center @ Danvers, Danvers, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952662710 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 272770 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northeast Hospital Corporation | Beverly, MA | Hospital |
Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northeast Medical Practice Inc | 2365405024 | 188 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
Jack Griffin, an internationally acclaimed and admired expert on diseases of the peripheral nervous system, founding director of the Johns Hopkins Brain Science Institute, and former director of Hopkins School of Medicine's Department of Neurology, died Saturday, April 16, after a long battle with bladder cancer. He was 69.
Republicans on both sides of the Capitol are investigating technical problems with the health law's online health insurance marketplaces - with one senator going so far as to call for the resignation of Health and Human Services Secretary Kathleen Sebelius. Others bemoan the lost opportunity to publicize the balky rollout because public attention was focused instead on the government shutdown.
Adding stroke severity to a hospital 30-day mortality model based on claims data for Medicare beneficiaries with acute ischemic stroke was associated with improvement in predicting the risk of death at 30 days and changes in performance ranking regarding mortality for a considerable proportion of hospitals, according to a study in the July 18 issue of JAMA.
› Verified 9 days ago
Entity Name | Northeast Medical Practice Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235147760 PECOS PAC ID: 2365405024 Enrollment ID: O20050111000265 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
Jack Griffin, an internationally acclaimed and admired expert on diseases of the peripheral nervous system, founding director of the Johns Hopkins Brain Science Institute, and former director of Hopkins School of Medicine's Department of Neurology, died Saturday, April 16, after a long battle with bladder cancer. He was 69.
Republicans on both sides of the Capitol are investigating technical problems with the health law's online health insurance marketplaces - with one senator going so far as to call for the resignation of Health and Human Services Secretary Kathleen Sebelius. Others bemoan the lost opportunity to publicize the balky rollout because public attention was focused instead on the government shutdown.
Adding stroke severity to a hospital 30-day mortality model based on claims data for Medicare beneficiaries with acute ischemic stroke was associated with improvement in predicting the risk of death at 30 days and changes in performance ranking regarding mortality for a considerable proportion of hospitals, according to a study in the July 18 issue of JAMA.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Susan Choe, DO Provider Enrollment Dept. Lahey Clinic Inc, 41 Mall Road, Burlington, MA 01805-0001 Ph: (781) 744-8085 | Susan Choe, DO Lahey Outpatient Center @ Danvers, 480 Maple Street 1st Fl, Danvers, MA 01923 Ph: (978) 304-8360 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
Jack Griffin, an internationally acclaimed and admired expert on diseases of the peripheral nervous system, founding director of the Johns Hopkins Brain Science Institute, and former director of Hopkins School of Medicine's Department of Neurology, died Saturday, April 16, after a long battle with bladder cancer. He was 69.
Republicans on both sides of the Capitol are investigating technical problems with the health law's online health insurance marketplaces - with one senator going so far as to call for the resignation of Health and Human Services Secretary Kathleen Sebelius. Others bemoan the lost opportunity to publicize the balky rollout because public attention was focused instead on the government shutdown.
Adding stroke severity to a hospital 30-day mortality model based on claims data for Medicare beneficiaries with acute ischemic stroke was associated with improvement in predicting the risk of death at 30 days and changes in performance ranking regarding mortality for a considerable proportion of hospitals, according to a study in the July 18 issue of JAMA.
› Verified 9 days ago
Margaret Legner, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Lahey Primary Care, Danvers, 5 Federal Street 1st Floor, Danvers, MA 01923 Phone: 978-777-6544 | |
Dr. Edward J Loughery, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 480 Maple Street, Northeast Cardiology, Danvers, MA 01923 Phone: 978-304-8360 Fax: 978-304-8320 | |
B. Geoffrey Piken, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 5 Federal St, Danvers, MA 01923 Phone: 978-774-0730 | |
Dr. Timothy M Loughran, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 480 Maple St Ste 204, Danvers, MA 01923 Phone: 978-774-0989 | |
Mauri Roger Cohen, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5 Federal Street, Lahey Health Primary Care, Danvers, Danvers, MA 01923 Phone: 978-750-0200 Fax: 978-450-0220 | |
Ruili Gu, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Hutchinson Dr, Danvers, MA 01923 Phone: 978-739-6950 Fax: 978-777-9274 | |
Michelle Hyunju Lee, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 102 Endicott St, Danvers, MA 01923 Phone: 617-643-7972 |